One80 Intermediaries’ Post

Check out this HCPLive segment focusing on the nuances of treating plaque psoriasis, psoriatic arthritis and psoriasis in skin of color! Thanks to my amazing colleagues for such a rich discussion! #psoriasis #bridgingthegap #psoriaticarthritis

Having the right partner in clinical research saves time and resources, on your path to approval. True North Contract Research is a reputable contract research organization that is a committed partner to innovators and organizations making a real difference in delivering ophthalmic solutions. If you would like to discuss our research strategies and unpack your roadmap to approval, contact True North Contract Research today. #contractresearch #truenorthcontractresearch #truenorth #clinicalresearch #ophthalmology #ophthalmicinnovation 

Did you know 55 to 58% of all patients seeking eyecare have Demodex blepharitis (DB)? Join Drs. Preeya Gupta, MD, and Doug Devries, OD, to discuss how to identify and manage Demodex blepharitis, clinical pearls for prescribing XDEMVY–the first and only FDA-approved treatment, and much more. Learn more: https://hubs.ly/Q02mr5Mw0 #eyecare #demodexblepharitis

How can sponsors overcome their biggest challenges in ophthalmic studies? Nicole Derthick, Therapeutic Strategy Lead, has actionable advice based on years of experience helping sponsors complete their trials. Check out her thoughts. https://lnkd.in/gSbwfJuz ____________________________ #ophthalmology #lifesciences #ophthalmology

Ophthalmic C-suite news from Market Scope: Sydnexis, of Del Mar, California, announced July 16 that Perry J. Sternberg had been appointed chief executive officer and as a member of the board of directors. He will join the company on Aug. 5, Sydnexis said. Sydnexis is developing SYD-101, an #atropine formulation to slow the progression of pediatric #myopia. The Phase III STAR study is investigating two dosage strengths of SYD-101 in more than 850 children ages 3 to 14. #industrymoves #ophthalmology

💡 Exciting news in the medical device industry! Merit Medical Systems is acquiring EndoGastric Solutions for $105M. This move is expected to bring significant advancements in the treatment of gastroesophageal reflux disease (GERD). The EsophyX Z+ device offers a minimally invasive solution that could be a game-changer for patients suffering from chronic GERD. Fred Lampropoulos, Merit’s chairman and CEO, emphasized that this acquisition aligns with their growth initiatives and enhances their product portfolio. It’s heartening to see how strategic decisions can pave the way for better patient outcomes. 🔍 Insight: Investing in innovative, patient-focused solutions not only drives business growth but also transforms lives. #HealthcareInnovation #MedicalDevices #GERD #PatientCare To learn more check out the full article: https://lnkd.in/g68mqsAR

Thinking about participating in an alopecia areata clinical trial or curious about the process? Hear from those who did and what they experienced on their journey. Panelists Brandi Meyer, April Noel, and Sandra Kelberlau will discuss their paths to joining a clinical trial and how those decisions have impacted living with alopecia areata for them. Panelist Katie Robberson will share her perspective as a parent considering clinical trial enrollment for her child. Dermatologist Dr. Tiffany Mayo will join the panel to answer medical questions. Wed., May 22 @ 7PM ET/4PM PT Join the webinar to learn more and get answers to your questions. https://lnkd.in/erwkwH6p

EyeWorld Online Exclusive Article Feature I'm thrilled to share that my pilot study on the Nanodropper Adaptor has been featured in an exclusive article by Liz Hillman in the June 2024 issue of EyeWorld Glaucoma. The Nanodropper Adaptor, a screw-on cap delivering a smaller drop of medication, has significantly improved compliance among my patients using Rhopressa and Rocklatan. In a small pilot study, 75% of participants experienced reduced redness and irritation, enabling them to continue their prescribed regimens. This innovation has allowed me to leverage the benefits of these medications while minimizing side effects, enhancing patient outcomes. Read more about our findings and the potential impact of this technology here: https://lnkd.in/eJ6ymH-e #Glaucoma #EyeCare Nanodropper, Inc. Alcon #PatientCare #Innovation #MedicalResearch #drokeke #AGEInitiative

Decoding Platelet Rich Plasma: A Comprehensive Guide to Evaluating PRP Kits with 15 Essential Metrics for Optimal Clinical Decision-Making Dive into this insightful article to uncover the 15 critical metrics needed to accurately assess Platelet Rich Plasma kits and protocols. With a focus on standardizing evaluation methods, this guide equips clinicians with the tools to compare PRP products effectively. Learn how to navigate the complexities of PRP therapy with clear, data-driven insights and recommendations for enhancing the effectiveness of this growing treatment modality. Authors: Don Buford, MD, FAANA, RMSK, Nathan Sherman, MD

🔥 In-Depth Insight from EADV 2024! Dr Menno Gaastra from Centrum Oosterwal shares how joint ventures between private clinics and academic hospitals are transforming dermatology care: - Enhancing patient care pathways by reducing wait times and improving access to second-line care. - Alleviating hospital workloads while maintaining financial sustainability. - Generating significant cost savings for both healthcare providers and the government. Discover these updates.👇 For all EADV 2024 videos, find the link in the comments! #MediMix #EADV2024